VentriLinks is a biotech intelligence platform that helps startups access comprehensive investor and biopharma partner databases, discover non-dilutive funding opportunities, and connect with the right investors, partners, and academic collaborators to accelerate fundraising, partnering, and IP commercialization. For biotech startups: Find investors, non-dilutive funding opportunities, and biopharma partners, research fit using curated profiles, optimize pitch/business decks, run targeted outreach, gain exposure to matched investors and partners, and access academic IP/technologies and licensable assets. For VCs: Discover matched, curated, high-quality deal flow with comprehensive startup profiles, decks, and insights, and source academic IP/technologies and spinout opportunities. For biopharma partners: Identify and engage startups and academic technologies aligned with your therapeutic focus, modality, and pipeline needs for licensing, co-development, and acquisitions. For academic institutions: List IP and technologies, manage multiple licensable assets, and get discovered by startups, VCs, and biopharma partners seeking academic innovation and partnerships.
| Website | https://www.ventrilinks.com/ |
| Employees | 6 (4 on RocketReach) |
| Founded | 2025 |
| Address | 100 Walnut Ave, Clark, New Jersey 07066, US |
| Industry | Biotechnology Research |
Looking for a particular VentriLinks employee's phone or email?
Ruhaan Munjuluri is the Co-Founder of VentriLinks.
4 people are employed at VentriLinks.
VentriLinks is based in Clark, New Jersey.